Atovaquone [clinicaltrials_resource:ca46516b5186c0e40c43d8e897688441]
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children [clinicaltrials:NCT00000773]Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis [clinicaltrials:NCT00000794]A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [clinicaltrials:NCT00000802]A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children [clinicaltrials:NCT00000811]An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine [clinicaltrials:NCT00001990]A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia [clinicaltrials:NCT00001991]A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole [clinicaltrials:NCT00001996]A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX [clinicaltrials:NCT00002340]Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America [clinicaltrials:NCT00084227]clinicaltrials:NCT00379821Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients [clinicaltrials:NCT00421473]clinicaltrials:NCT00444106Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) [clinicaltrials:NCT00636935]clinicaltrials:NCT00984256clinicaltrials:NCT01150344Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria [clinicaltrials:NCT01442168]clinicaltrials:NCT01479361Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension [clinicaltrials:NCT01858831]clinicaltrials:NCT02080026Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection [clinicaltrials:NCT02098590]The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia [clinicaltrials:NCT02297477]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Atovaquone [clinicaltrials_resource:ca46516b5186c0e40c43d8e897688441]
Bio2RDF identifier
ca46516b5186c0e40c43d8e897688441
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ca46516b5186c0e40c43d8e897688441
identifier
clinicaltrials_resource:ca46516b5186c0e40c43d8e897688441
title
Atovaquone
@en
type
label
Atovaquone [clinicaltrials_resource:ca46516b5186c0e40c43d8e897688441]
@en